The 2024 PM360 Pharma Choice Awards – App/Digital Bronze Winner

BrightInsight and CSL Behring

The Hizentra App

The Hizentra® app was developed to support patients transitioning from in-clinic treatment to at-home self-infusions of Hizentra and to stay compliant. We conducted interviews with patients and physicians to understand the challenges in moving to selfadministered infusions. The app was designed to help patients properly self-infuse and stay compliant by enabling patients to easily track infusions and infusion sites, set reminders, and record and share their infusion journal with their doctor.

BrightInsight TEAM MEMBERS:
Kimberly Berger Global Accounts Director
Gary Wirth Global VP, Customer Solutions
Anisha Gururaj Director, Clinical Launch Success & Data Strategy
Andrew Tucker Director, Solution Owner Team
Johnathan Do Staff Solution Owner
Gokul Kulkarni Staff Software Engineer
Subbu Sankarasubbu Senior Manager, Platform Engineering
Sarah Matthews Manager, Program Manager

CSL BEHRING TEAM MEMBERS:
Brian Johnson Senior Director, Customer Engagement
Cindy Blackburn Director, Digital Health
Soroush Abidi Senior Manager
Phanikrishna Karnati Associate Director, Global Commercial & IT
Dan McNulty Associate Product Manager for Hizentra
David White Director, Commercial IT Platforms

Ads

You May Also Like

2019 Pharma Choice Multichannel Gold Winner Neon and Novartis

Neon, An FCB Health Network Company Novartis Elevate Enthesitis Inspired by the need to ...

2017 Pharma Choice Gold Unbranded

Biosector 2 Sunovion Pharmaceuticals Inc. Be Vocal: Speak Up for Mental Health Be Vocal: ...

9 Marketing Trends to Watch for in 2024—Beyond AI

Our readers share the trends they feel life sciences marketers cannot ignore in 2024 ...